- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Oncolytic viruses for cancer immunotherapy ; volume:13 ; number:1 ; day:29 ; month:6 ; year:2020 ; pages:1-15 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (29.6.2020), 1-15, 12.2020
- Urheber
-
Hemminki, Otto
Santos, João Manuel dos
Hemminki, Akseli
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00922-1
- URN
-
urn:nbn:de:101:1-2020082421454193753823
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hemminki, Otto
- Santos, João Manuel dos
- Hemminki, Akseli
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Oncolytic viruses as therapeutic cancer vaccines
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Two roads for oncolytic immunotherapy development
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Oncolytic virus immunotherapy: future prospects for oncology
Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Oncolytic viruses as therapeutic cancer vaccines
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Two roads for oncolytic immunotherapy development
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Oncolytic virus immunotherapy: future prospects for oncology
Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Oncolytic viruses as therapeutic cancer vaccines
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Two roads for oncolytic immunotherapy development
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Oncolytic virus immunotherapy: future prospects for oncology